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Toxicology Testing Requirements and the
U.S.-Japan Collaborative Study on In
Vitro TestsforChromosomal Aberrations
by M. D. Shelby* and T. Sofunit
AspartoftheU.S-JapanAgrementonCooperation inResearthandDevelopmentinScienceand IIchnolo,Japase
andAmerican scientists metinNorthCarina toehang infonnation ontoioloytestingrequirements andguidelines
inthetwocountriesandtoreviewprges inacollaborative shtdy ondetectionofchemicaflyinducedchromosomal aber-
rations incultured mammaliancefls.
Introduction
Ameeting washeldApril2-6, 1990, betweenscientists from
theU.S. andJapan (seetheappendix forlistofparticipants) as
partoftheU.S.-Japan Agreement onCooperation inResearch
and Development in Science andTechnology. This was the se-
cond joint meeting (1) to exchange information on the tox-
icologicalcharacterizationofenvironmentalchemicalsofmutual
interest. The emphasis ofthis meeting was on comparisons of
short-termgenetictoxicitytestingrequirements inthetwo coun-
triesandspecifically onthecell typesandprotocols used forin
vitro tests for chromosomal aberrations.
RegulatoryRequiementsforTboicologicalStudies
The first 2 days of the meeting focused on regulatory re-
quirementsand oncontinuing efforts to assessthevalueandrole
ofshort-termin vitroandin vivogenetictoxicity teststoidentify
chemicals thatmight present ahealth hazard to humans.
U.S. tesfingrequirementsandguidelines werepresentedbyD.
Jacobson-Kram. It waspointed out inhis talkthatthedifferent
regulatory agencies intheU.S. takedifferentapproaches tothe
use ofshort-term tests; the tests required or recommended, as
well asthe structures ofthetesting schemes, vary among agen-
cies aswell as amongdivisions within an agency. An encourag-
ingactivity, albeitsomewhatcomplicating atthepresent, isthe
reviewandrestructuringoftestingguidelinesby someregulatory
agencies.
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M. Ishidate, Jr., presented the genetic toxicity tests and test
schemes requiredby various ministries inJapan; Y. Kurokawa
gave a similar overview ofall toxicity testing requirements in
Japan. The situation inJapan is very similarto thatin the U.S.
in thata variety ofpublichealth laws have led to a rangeofre-
quiredtestsandtestingschemesamongtheministriesresponsi-
ble forpublic health.
Despite some differences in the required or recommended
tests in the two countries, the underlying concerns for human
healtharethesame. Cancerandgeneticdiseasearetheprimary
concerns to which the application ofgenetic toxicity tests are
directed.
Evaluation ofChemical GeneticToxicity
In the session on evaluation ofchemical genetic toxicity, E.
Zeigerreviewedthecourseofshort-termtestingintheU.S. Na-
tionalToxicology Program(NTP). Currenttestingactivitiesa)
employasmallernumberofinvitroteststhanthefourpreviously
used,b)includetheprudentuseofshort-termin vivotests, par-
ticularlythemicronucleustest,andc)placeincreasedemphasis
onintegratedstudiesdesignedtocharacterizeandunderstandthe
genetictoxicityofspecificchemicalsratherthanthemassscreen-
ingofchemicals. M. Ishidatestatedthat, inJapan, expertcom-
mitteesreviewmutagenicpotencyinformationtohelpcategorize
the level of risk that might be associated with a mutagenic
chemical andtodetermineadditional testing needs.
Results ofmutagenicity studies using new strains ofSalmo-
nellathathavebeenengineeredtohaveincreasedlevelsofnitro-
reductaseandacetyltransferasewerepresentedby T. Nohmi. The
newstrainshaveprovenverysensitivetolowlevelsofaromatic
aminesandnitroaromatics. M. Shelby presentedcomparisons
ofinvitroandinvivoshort-termtestresultsfromNTP-sponsored
studies. With regard to rodent carcinogens, levels of con-SHELBYAND SOFUNI
cordance ofshort-term in vivotests were similartotheconcor-
dances ofin vitro short-term tests, i.e., 60to75%. Shelby sug-
gestedcaution inattempting topredictcarcinogensbasedstrictly
ontheresultsofroutineshort-termtestingandpointedouttheim-
portantceofconductingchemical-specific studieswhereroutine
tests do not present clearevidence ofgenetic toxicity.
The final twopresentations inthis session wereonthetopicof
nongenotoxic carcinogens. Y. Kurokawapresentedtheresultsof
a series of experiments on the formation of 8-hydroxy-
deoxyguanosine intheDNAofrodentstreatedwithcarcinogens,
particularly those carcinogens that are thought to act through
oxidativedamagetoDNA. Heemphazisedtheneedforstudying
the relationships between oxidative DNA damage and cell
proliferation. Kurokawanotedthat, basedontheresultsofrecent
NTP cancer studies and the criteria currently used to select
chemicals for such studies, asubstantial increaseinthenumber
of nongenotoxic rodent carcinogens is inevitable. R. Tennant
reviewedactivities andplans intheNTPtodevelopmethodsfor
detectingchemicalsthatmightbenongenotoxiccarcinogens. He
discussedthevarietyofchemical structurescontainedwithinthis
categoryofcarcinogensandreviewedarangeofmechanismsby
which they might cause neoplasia, mechanisms such as cell
proliferation, alterationsintranscription, oroncogeneactivation.
CHL-CHO Collaborative Study
ThesessionontheCHL-CHO(Chinesehamsterlung-Chinese
hamsterovary)CollaborativeStudystartedwithpresentationsof
theprotocolsthatarebeingused intheCHL-CHOchromosome
aberrationcollaborative study. T. Sofunipresentedthedetailsof
theprotocol used to test for inductionofchromosomal aberra-
tions inCHLcellsinJapan. B. Andersonpresenteddetailsofthe
CHO chromosomal aberration assay usedby the NTP.
The progress in a collaborative study to investigate the dif-
ferences intestresultsobtainedintheinvitrochromosomalaber-
ration test required in Japan (CHL system) and the CHO test
system used by the NTP was reviewed by Sofuni. Results ofa
testingcomparison carried outby theNIHS (National Institute
ofHygienic Sciences) and the NTP on 25 chemicals (Table 1)
have been published (2). Following submission ofthat manu-
script, otherlaboratories intheU.S. andtheU.K. expressed in-
terest inparticipating infurthereffortstodefinethereasonswhy
thetwotestsystemsdonotalwaysyieldthesameresults. Thegoal
is todevise a moreinternationally acceptable systemfordetec-
tingtheinductionofchromosomalaberrations inculturedmam-
malian cells.
Thelast2daysofthemeeting werechairedbyM. Ishidateand
S. Galloway and were conducted as roundtable discussions of
several issues related totheconductofin vitroaberration assays.
These issues included the determination of cytotoxicity and
selectionoftestdoses, treatmentandharvesttimes,metabolic ac-
tivation systems, negativeandpositivecontrols, andscoringand
classification ofaberrations.
Metabolic Activation
S. Galloway discussed results of her metabolic activation
studies usingCHOcells tocomparetheS9conditions fromthe
CHL assay and CHO assay protocols. With regard to treating
libIe1.ChemicalstestedforinductionofchromwsomalaberrationsinCHL
and CHOcells (2).
Chemical
no.
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17
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2,3,4-Trichlorophenol
2,3,6-Trichlorophenol
3,4,5-Trichlorophenol
2,3,4,5-TetrachIorophenol
2,3,4,6-Tetrachlorophenol
2,3,5,6-Tetrachlorophenol
o-Phenylenediamine
m-Phenylenediamine
2,6-Toluenediamine dihydrochloride
N,N-Dimnethyl-p-phenylenediamine
N,N,N'N'-Tetramethyl-p-phenylenediamine
N,N-Diethyl-p-phenylenediamine
N,N'-Di-sec-butyl-p-phenylenediamine
N,N'-Diphenyl-p-phenylenediamine
N,N'-Di-2-naphthyl-p-phenylenediamine
N-Phenyl-l-naphthylamine
N-Phenyl-2-naphthylamine
p-Isopropoxydiphenylamine
4,4'-Dimethoxydiphenylamine
4,4'-Dioctyldiphenylamine
N-Nitrosodiphenylamine
Tris(2,3-epoxypropyl)isocyanurate
Triallyl isocyanurate
Chromium carbonyl
1-(1,2-Dibromoethyl)-3,4-dibromocyclohexane
CAS no.
15950-66-0
933-75-5
609-19-8
4901-51-3
58-90-2
935-95-5
95-54-5
108-45-2
15481-70-6
99-98-9
100-22-1
93-05-0
101-96-2
74-31-7
93-46-9
90-30-2
135-88-6
101-73-5
101-70-2
101-67-7
86-30-6
2451-62-9
1025-15-6
13007-92-6
3322-93-8
cellsinserum-freeorserum-containingmedium, shenotedthat
the protein concentration in medium containing 10% serum
could be as much as seven times that in serum-free medium
containing only S9 mix. In tests for sisterchromatidexchange
(SCE) induction with dimethylnitrosamine (DMN), benzo-
(a)pyrene (BP), and cyclophosphamide (CP), the presence of
serumdidnotchangetheresponsestoDMNorBPbutmarkedly
suppressedthelevel ofSCEinducedby CP. Serumsuppressed
theinductionofchromosomalaberrationsbyBPandCPbutdid
notaffectthe responseto DMN.
Gallowayalsopointedoutthatincurrentstudies, sheusesS9
inducedwithphenobarbitalplus,B-naphthoflavone. Withthis S9,
the response ofthe positive control is not different from that
obtained with Aroclor 1254-induced S9 used for the NTP
studies. In her laboratory, the incidences ofcontrol cells with
aberrations wasthesamewithorwithoutS9(about2% cellswith
aberrations) regardless of whether the enzyme inducer was
Aroclor orphenobarbital plusf3-naphthoflavone.
AmountofS9and Cofactors
WithregardtothevolumeofS9mixusedintreatmentmedium
(15AL/mListypicallyusedintheCHOsystem, whiletheCHL
protocolcallsfor50uL/mL). S. Gallowayfoundthat 15t&L/mL
ismoreeffectivethan501L/mLwithCP, whereasforDMN, 50
tsL/mLgivesahigherresponsethan 15yL/mL; theeffectofBP
wasslightlyhigherwith50 tL/mL. HerstudieswithS9cofactors
indicated that only small differences resulted from the dif-
ferencesincofactorsortheirconcentrationsusedwith CHOand
CHLprotocols. ThevolumeofS9appearsto-bemoreimportant
thantheconcentrationsofcofactorsbut, asnotedabove, nosingle
volume canbeconsideredoptimal forall chemicals.
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Exposure Time
S. Galloway compared two incubation times with S9, 6hr as
intheCHLprotocol, and3hr(theCHONTPprotocolused a2
hr treatment with S9). Inthis comparison, S9 exposure was in
medium containing serum. WithDMN, higherSCEfrequencies
wereobtained with6hr exposure, butforCPandBPthere was
littleimprovementinSCEyield, andtoxicityand cellcycledelay
were moremarked at6hr than at3 hr,particularlyforBP. There
wasgeneral agreement thattreatmentwith S9shouldbelonger
than the2 hrused intheNTPprotocol andperhaps not as long
as the 6 hrused in the CHL system. Shealsoconcluded that at
least for some chemicals (e.g., triallyl isocyanurate), the dif-
ferenceinresultswithS9betweenCHLandCHOtestscouldbe
attributed tothelengthoftimebetweentreatmentandcellharvest
rather than differences inS9 exposureconditions.
ForCHO cells, Galloway is nowusing a3-hr treatmenttime
bothwithandwithoutS9and a20-hrharvest asherstandardtest.
Shepresenteddatashowingthatfollowing a3-hrtreatment, the
percentageofaberrant cells and theaberrations percelldo not
peak atthe sametimebutthat a20-hrharvestreliably detected
aneffectfor awidevarietyofchemicals ifthedoses wereproper-
ly chosen.
M. Ishidatepointed outthatthemaindifferencesbetweenthe
CHLandCHOprotocols are treatmenttimeandvolumeofS9.
IntheCHL system, continuous treatmentwithS9mixfor24and
48hr ensures treatmentofcellsinall stagesofthecellcycleand
might detect some chemicals for which CHL cells have a low
levelofmetabolicactivationcapability. Thechoiceofa6-hrin-
cubationtimewithS9intheCHLsystem wasbasedontheobser-
vationthattreatmentwithS9ofmonolayercultures for6hr was
more sensitive than treatment in suspension for 3 hr.
Preliminary Results ofCell Type Comparisons
R. Marshallpresentedresultsofstudies atHazletonMicrotest
(U.K.) wherein4ofthe25 NTP/NIHS chemicals weretestedin
CHL, CHO-WBL (used in NTP tests), CHO-UK, and human
lymphocytes foraberration induction. Threeofthesechemicals
werephenylenediamines; thefourth wastriallylisocyanurate. All
were positive in CHL and negative in CHO in the NTP/NIHS
study (2). Inall cases, cells were treated without S9 for20and
44hrandharvested atthese times. N,N-dimethyl-p-phenylene-
diamine andN,N-diphenyl-p-phenylenediamine werepositive in
all fourofMarshall's test systems includingthe CHOcells. He
notedconsiderablevariability inthedoselevelsthatledtomitotic
inhibition and aberration induction among the four cell types.
N,N-di-2-naphthyl-p-phenylenediamine was negative in all four
cell systems, but the doses tested were much lower than those
foundpositiveatNIHS. Triallylisocyanurate wasweaklypositive
in human lymphocytes only. The reason for Marshall's use of
lowerdoses wastoremainwithinthe rangeofsolubilityofthetest
chemicals. Theseresultsagain suggestthat aharvesttimegreater
thantheapproximately 12hrusedby NTPis necessary todetect
the induction ofaberrations by somechemicals.
Discussions following Marshall'spresentation ledto a consen-
sus that tests could be conducted over adose rangethat includ-
edprecipitating dosesbutthatdoses withoutprecipitate should
beincluded. Also, T. Sofuniagreedto use afinal concentration
ofdimethylsulfoxide of 1% (v/v) ratherthan0.5% as currently
used. This would be consistent with the CHO protocol and
shouldpermitmorecomparabledosingbetweenthetwosystems.
Dimethylsulfoxidewillbethesolventusedforallchemicals in
thecollaborative study.
Sofuni presented preliminary results of cell-stage analyses
(MI, M2,etc.)withbromodeoxyuridine ontwochemicalsusing
bothCHLandCHOcells. Hisresultsshowremarkablecellcy-
cledelay incellstreatedwithhigherdosesofthetestchemicals
for24 and48 hr.
ScoringAberrations
Amajorissueofconcernhasbeenthatthedifferentresultsob-
tainedwiththeCHLandCHOsystemsmightarisefromtheuse
ofdifferent scoringconventions inthe U.S. andJapan. Tohelp
resolve this issue, photographs and microscope slides were
reviewed at the meeting. In the end, it appeared that there is
agreement on scoring most categories and major aberrations.
Theprimarydifferencethatexistsisinthescoringofachromatic
lesions(gaps)andchromatidbreaks. T. SofuniandM. Ishidate
ignoremanyofthesmallunstainedregions (lessthanthewidth
ofachromatid). Theotherparticipantsrecordtheseregions(less
thanthewidthofachromatid) as gapsbutdo notincludethem
in theevaluationofresults. TheJapaneserecordasgapsandin-
cludeintheirevaluationofresultsmanyofthelarge, unstained
regionsthattheotherinvestigatorsconsideredchromatidbreaks
byvirtueoftheirlengthorslightdisplacement. Despitethedif-
ference in nomenclature, there is apparently only one class of
chromosomedamagethatmightbescoreddifferentlybyinvesti-
gators inthetwocountries. Unstained (orvery lightly stained)
regions ofa chromosome that are longer than the width of a
chromatid, arenotspatiallydisplaced,andmayormaynotappear
tocontainchromosomalmaterialwouldbescoreda"gap"bythe
Japaneseinvestigatorsanda"break"bytheotherinvestigators.
The result of this work session was a much better under-
standing ofthe scoring conventions in the two countries, and,
although somedisagreements stillexist, everyoneunderstands
thedifferentscoringcriteria. Itwassuggestedthatinsubsequent
workinthiscollaborativestudy, participating laboratoriesmay
wantto noteon their score sheets breaks orgaps thatwouldbe
scoreddifferentlybyanotherlaboratory. Thiswouldmakecom-
parison ofresults easierwhenthetesting is completed.
Plans forCollaborative Study
Infurthercomparativestudies, fourtestswillbeconductedon
selectedchemicals; CHLcellsusingCHLprotocol, CHLcells
usingCHOprotocol, CHOcellsusingCHOprotocol, andCHO
cells using CHL protocol. Protocol differences that were not
discussedextensivelyatthismeetingbutwhichareofimportance
inthecomparative study are listed inTable 2.
Table2. Additional protocoldifferences.
CHLprotocol CHOprotocol
Cells seeded 3 daysbeforetest Cells seeded24hrbeforetest
Nochangeofmedium Fresh medium attimeoftreatment
Mediumcontains calfserum Mediumcontains fetal calfserum
6hr, -S9control in +S9 test No suchcontrol
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In other studies, a setofslides to bereadby each ofthepar-
ticipatinglaboratorieswillbecirculatedtopermitanassessment
ofinterlaboratorydifferencesincellselectionandscoringaswell
asinformationonhowdifferentlaboratoriesscorethesamecells;
bromodeoxyuridine will be used to determine the metaphase
(Ml, M2, etc.) inwhichaberrations are scored; andtheeffects
ongrowthkineticsofcalfserumon CHOcells andoffetalcalf
serum on CHLcells willbeinvestigated todetermine iftheef-
fects are largeenough tojustify adjustment ofharvesttimes.
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